Two more biotechs, Marea and North Immunology, do reverse mergers

The reverse merger party is still buzzing. This time, it's a cardio and endocrine startup with two drugs in Phase 2 and a biotech working on a long-acting immunology and inflammation (I&I) drug. Mid-stage Marea ...